Literature DB >> 442080

Adriamycin instillation therapy for bladder tumors.

T Mishina, T Fujiwara, K Miyakoda, H Araki, T Kobayashi, M Saitoh, H Watanabe.   

Abstract

Topical instillation of Adriamycin, 40 mg in 20 ml sterilized distilled water, was performed in 20 cases of bladder tumors every day for two weeks. In 8 cases (40%) the tumors disappeared completely, while in 5 cases (25%) tumors were reduced in size, but in 7 cases (35%) there was no effect. Therefore, the rate of effectiveness was 65%. The local bladder reaction and urethral pain were noted in all cases, as a result of which the therapy was interrupted in 2 cases. Abnormal values of red blood cells, white blood cells and platelets were not observed. In 3 cases the serum level of Adriamycin was only trace 1 or 2 hr after instillation. In conclusion, Mitomycin C was thought to be superior to Adriamycin as far as the effectiveness and irritability on the normal bladder epithelium were concerned.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 442080     DOI: 10.1620/tjem.127.339

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  3 in total

1.  Size and location of tumors influencing the effect of bladder instillation therapy.

Authors:  H Watanabe; M Nakao; S Nakagawa; H Takada
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Development and clinical application of an AFC regimen (adriamycin, futraful, cytosine arabinoside) for superficial bladder tumors.

Authors:  T Mishina; T Kobayashi; M Maegawa; M Nakao; S Nakagawa
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Intravesical instillation of adriamycin for bladder tumors.

Authors:  H Ohe; H Watanabe; T Mishina; M Kojima; S Nakagawa
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.